MedPath

A new perspective: Development of a cognitive behavioral therapeutic intervention for patients with remaining trauma related symptoms

Conditions
post-traumatic stress disorder
PTSD
10002861
Registration Number
NL-OMON53700
Lead Sponsor
Reinier van Arkelgroep (Den Bosch)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
44
Inclusion Criteria

- All participants are adult (18-63 years)
- All adutls are competent
- All participants have undergone trauma focused treatment
- Despite this treatment, participants continue to experience trauma related
symptoms (PCL score of 33 or more)

Exclusion Criteria

- Participants who do not have trauma related symptoms
- Participants whose attitude towards the intervention is not in line with the
goal of the study (e.g. participant primarily expects symptom reduction instead
of improvement in quality of life)
- Participants who do not have sufficient mastery of the Dutch language
- Participants who show an acute high risk for suicide
- Participants who actively and excessively use substances
- Participants who show behavioral problems causing interpersonal conflicts
and/ or disturbing the group proces
- Participants who are suspected to or diagnosed with simulation (as
demonstrated by clinical asessment)
- Participants whose mental capacity is limited (as demonstrated by clinical
asessment)
- Participants whom have a psychological/psychotherapeutic treatment during the
experimental intervention
- Participants of which their medication is altered during the experimental
intervention

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Self-report questionnaires are used to measure quality of life (MANSA-12vn),<br /><br>attribution style (experimental questionnaire), trauma related cognitions<br /><br>(PTCI), and trauma related symptoms (PCL-5).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>N.A.</p><br>
© Copyright 2025. All Rights Reserved by MedPath